Mavelertinib (PF-06747775) is an orally available, selective and potent EGFR tyrosine kinase (EGFR TKI) inhibitor with inhibitory effects on T790M/L858R and T790M/Del, and can be used in the study of oncology and respiratory diseases.
Molecular Weight:
415.42
Purity:
99.89%
CAS Number:
[1776112-90-3]
Formula:
C18H22FN9O2
Target:
EGFR
T21322
* VAT and and shipping costs not included. Errors and price changes excepted